Safety and Efficacy of Benzalkonium Chloride-optimized Tafluprost in Japanese Glaucoma Patients With Existing Superficial Punctate Keratitis
| Autor: | Miho Enoki, Koh Hei Sonoda, Kayoko Tokuhisa, Rie Shiraishi, Y. Ishida, Shinji Hirano, Masako Nakayama, Makiko Wakuta, Norihisa Takahashi, Hideaki Yoshino, Shinichiro Teranishi, Katsuyoshi Suzuki, Yukiko Kondo, Yoshihisa Nuno, Takeshi Sagara |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Male
Intraocular pressure medicine.medical_specialty Glaucoma Tonometry Ocular chemistry.chemical_compound Asian People Ophthalmology Humans Medicine Prospective Studies Latanoprost Prospective cohort study Antihypertensive Agents Intraocular Pressure Aged Aged 80 and over Keratitis Bimatoprost business.industry Preservatives Pharmaceutical Prostaglandins F Tafluprost Middle Aged medicine.disease Prostaglandin analog chemistry Female Ocular Hypertension sense organs Travoprost Benzalkonium Compounds business medicine.drug |
| Zdroj: | Journal of Glaucoma. 24:e145-e150 |
| ISSN: | 1057-0829 |
| DOI: | 10.1097/ijg.0000000000000020 |
| Popis: | PURPOSE To evaluate the safety and efficacy of benzalkonium chloride (BAK)-optimized tafluprost (with a BAK concentration reduced from 0.01% to 0.001%) in glaucoma patients with existing superficial punctate keratitis (SPK). PATIENTS AND METHODS A prospective, multicenter, open-label study was designed to compare BAK-optimized tafluprost administered over 12 weeks relative to other preserved prostaglandin analogs previously administered in Japanese glaucoma patients. Thirty patients with SPK graded at |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|